Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 28, 2024 |
| PDB ID ▲ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7PYY | A0A0S2GKZ1 | Structure of LPMO (expressed in E.coli) with cellotriose at 5.05x10^5 Gy | |
| 7PYZ | A0A0S2GKZ1 | Structure of LPMO (expressed in E.coli) with cellotriose at 2.97x10^6 Gy | |
| 7PZ0 | A0A0S2GKZ1 | Structure of LPMO (expressed in E.coli) with cellotriose at 9.81x10^6 Gy | |
| 7PZ3 | G3XAP7 | Structure of an LPMO at 5.37x10^3 Gy | |
| 7PZ4 | G3XAP7 | Structure of an LPMO at 2.07x10^4 Gy | |
| 7PZ5 | G3XAP7 | Structure of an LPMO at 9.56x10^4 Gy | |
| 7PZ6 | G3XAP7 | Structure of an LPMO at 2.22x10^5 Gy | |
| 7PZ7 | G3XAP7 | Structure of an LPMO at 1.13x10^6 Gy | |
| 7PZ8 | G3XAP7 | Structure of an LPMO at 3.12x10^6 Gy | |
| 7Q0A | P0DTC2 | SARS-CoV-2 Spike ectodomain with Fab FI3A | |
| 7Q0A | 7Q0A | SARS-CoV-2 Spike ectodomain with Fab FI3A | |
| 7Q0A | Q3I5J5 | SARS-CoV-2 Spike ectodomain with Fab FI3A | |
| 7Q0A | P0DTC2 | SARS-CoV-2 Spike ectodomain with Fab FI3A | |
| 7Q0A | 7Q0A | SARS-CoV-2 Spike ectodomain with Fab FI3A | |
| 7Q0A | Q3I5J5 | SARS-CoV-2 Spike ectodomain with Fab FI3A | |
| 7Q0G | 7Q0G | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-49 and FI-3A Fabs | |
| 7Q0G | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-49 and FI-3A Fabs | |
| 7Q0H | 7Q0H | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-50 and Beta-54 | |
| 7Q0H | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-50 and Beta-54 | |
| 7Q0I | 7Q0I | Crystal structure of the N-terminal domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-43 | |
| 7Q0I | P0DTC2 | Crystal structure of the N-terminal domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-43 | |
| 7Q0S | P13807 | Human GYS1-GYG1 complex inhibited-like state bound to glucose-6-phosphate | |
| 7Q0S | P46976 | Human GYS1-GYG1 complex inhibited-like state bound to glucose-6-phosphate | |
| 7Q12 | P13807 | Human GYS1-GYG1 complex activated state bound to glucose-6-phosphate | |
| 7Q12 | P46976 | Human GYS1-GYG1 complex activated state bound to glucose-6-phosphate | |
| 7Q13 | P13807 | Human GYS1-GYG1 complex activated state bound to glucose-6-phosphate, uridine diphosphate, and glucose | |
| 7Q13 | P46976 | Human GYS1-GYG1 complex activated state bound to glucose-6-phosphate, uridine diphosphate, and glucose | |
| 7Q15 | P55899 | Crystal structure of FcRn and beta-2-microglobulin in complex with IgG1-Fc-MST-HN (efgartigimod) | |
| 7Q15 | P61769 | Crystal structure of FcRn and beta-2-microglobulin in complex with IgG1-Fc-MST-HN (efgartigimod) | |
| 7Q15 | 7Q15 | Crystal structure of FcRn and beta-2-microglobulin in complex with IgG1-Fc-MST-HN (efgartigimod) | |
| 7Q1K | G3XAP7 | Crystal structure of the native AA9A LPMO from Thermoascus aurantiacus | |
| 7Q1L | P02787 | Glycosilated Human Serum Apo-tranferrin | |
| 7Q1M | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2S)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-2,2-diphenylacetamide | |
| 7Q1N | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2R)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-2,2-diphenylacetamide | |
| 7Q1O | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2S)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-3,3-diphenylpropanamide | |
| 7Q1P | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2R)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-3,3-diphenylpropanamide | |
| 7Q1W | A7B6A6 | Ruminococcus gnavus ATC29149 endo-beta-1,4-galactosidase (RgGH98) E411A in complex with blood group A (BgA II) tetrasaccharide | |
| 7Q1Y | A8K2U0 | X-ray structure of human A2ML1 | |
| 7Q1Z | P0DTC2 | Structure of formaldehyde cross-linked SARS-CoV-2 S glycoprotein | |
| 7Q20 | A7B6A6 | Ruminococcus gnavus ATC29149 endo-beta-1,4-galactosidase (RgGH98) in complex with blood group A trisaccharide | |
| 7Q24 | P12821 | Crystal structure of Angiotensin-1 converting enzyme N-domain in complex with dual ACE/NEP inhibitor AD011 | |
| 7Q25 | P12821 | Crystal structure of Angiotensin-1 converting enzyme N-domain in complex with dual ACE/NEP inhibitor AD012 | |
| 7Q26 | P12821 | Crystal structure of Angiotensin-1 converting enzyme N-domain in complex with dual ACE/NEP inhibitor AD013 | |
| 7Q27 | P12821 | Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with dual ACE/NEP inhibitor AD011 | |
| 7Q28 | P12821 | Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with dual ACE/NEP inhibitor AD012 | |
| 7Q29 | P12821 | Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with dual ACE/NEP inhibitor AD013 | |
| 7Q3N | Q1R2J4 | Cryo-EM of the complex between human uromodulin (UMOD)/Tamm-Horsfall protein (THP) and the FimH lectin domain from uropathogenic E. coli | |
| 7Q3N | P07911 | Cryo-EM of the complex between human uromodulin (UMOD)/Tamm-Horsfall protein (THP) and the FimH lectin domain from uropathogenic E. coli | |
| 7Q3P | 7Q3P | Crystal structure of IgG1-Fc-MST-HN (efgartigimod) | |
| 7Q3Q | A0A6H2EIN2 | Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobody VHH-12 |
